ALDR News and Press, Alder BioPharmaceuticals Inc. From 07/11/19

            - Posters presented at the 2019 American Headache Society meeting highlight eptinezumab’s safety profile and suppression of calcitonin gene-related peptide (CGRP) -              - N...

Alder BioPharmaceuticals (NASDAQ: ALDR ) resumed with Neutral rating and $14 (22% upside) price target at Credit Suisse. Shares up 1% premarket. More news on: Alder BioPharmaceuticals, Inc., HMS Holdings Corp., DaVita Inc., Healthcare stocks news, Stocks on the move, , Read more ...

BOTHELL, Wash., July 08, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that it will present new analyses of efficacy and quality of life da...

BOTHELL, Wash., June 19, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that it will webcast its upcoming breakfast symposium with key opini...

BOTHELL, Wash., June 18, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that Bob Azelby, Alder’s president and chief executive office...

AbbVie (NYSE: ABBV ) resumed with Neutral rating and $84 (5% upside) price target at Goldman Sachs. More news on: AbbVie Inc., Allergan plc, Alder BioPharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

The following slide deck was published by Alder BioPharmaceuticals, Inc. in conjunction with this Read more ...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you can re...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Retailers cap off the Q1 earnings season in style as Target (TGT), Best Buy (BBY), ...

BOTHELL, Wash., May 14, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that members of the management team will provide a business overview a...